10 Best Pure-Play Robotics Stocks to Buy Now

8. PROCEPT BioRobotics Corp. (NASDAQ:PRCT)

Market Cap: $1.4 Billion

Potential Upside: 17.3%

PROCEPT BioRobotics Corp. (NASDAQ:PRCT) is among the best pure-play robotics stocks to buy now. The company is considered a pure-play robotics company because its business is centered entirely on robotic-assisted surgical systems. It develops the AQUABEAM and HYDROS platforms, which are robotic systems used for minimally invasive urologic procedures.

On March 12, the company announced the international launch of its HYDROS robotic system, with the UK serving as the first market outside the U.S. HYDROS is the company’s next-generation, AI-enabled platform for Aquablation therapy to treat benign prostatic hyperplasia (BPH). The platform uses AI-powered real-time ultrasound imaging and image-guided planning to support anatomy-specific treatment with robotic precision.

Larry Wood, President & CEO, PROCEPT BioRobotics, believes the launch expands the company’s international footprint. He further stated:

“The HYDROS Robotic System expands international access to a clinically validated, next-generation AI-enabled robotic solution that delivers durable symptom relief while preserving quality of life. We are proud to bring this innovation to physicians and patients across the UK and to continue expanding our international footprint.”

Earlier, on February 25, Procept BioRobotics reported fourth-quarter revenue of $76.4 million and full-year revenue of $308.1 million, reflecting 37% growth. The company ended 2025 with an installed base of 718 systems in the U.S. and over 900 systems globally. For FY 2026, management expects revenue to grow by 27% to 33% to $390 million to $410 million.